This prospective study investigates the potential impact of glycated hemoglobin (HbA1c) levels on diabetic foot morbidity and explores its potential correlation with a range of clinical factors. Diabetic foot complications present a significant healthcare challenge, and HbA1c serves as a well-established marker for long-term glycemic control. Gaining insights into the potential relationship between HbA1c levels and foot morbidity holds the promise of enhancing patient care and management. The study employs [describe the study design, sample size, and Inclusion criteria], with a focus on categorizing participants’ HbA1c levels. Concurrently, clinical variables including neuropathy, vascular status, and foot deformities are evaluated.